arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Celldex Therapeutics, Inc.

CLDX

$41.72 ▲ +0.16 (+0.37%) at close

18 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Celldex Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.8B

Dividend Yield —

Revenue Growth -78.0% ↘

Op. Margin None

ROIC -54.5% ↘

FCF / Share $-3.22 ↘

Trailing P/E —

Price / Book 5.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.54M

↓ -78.0% —

Net Income Profit after all expenses

$-258.76M

↓ -63.9% —

Operating Margin Operating profit as % of sales

-468.4%

↓ -3295.6% —

FCF / Share Free cash flow per share

$-3.22

↓ -29.7% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	-78.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1075%)	2.0% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-75%)	192.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2300%)	-49.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-717%)	-37.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-566%)	107.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1245%)	-62.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-882%)	-25.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-414%)	87.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+997%)	23.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+198%)	52.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+560%)	-12.8% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-260%)	-63.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-891%)	20.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+161%)	-80.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1103%)	208.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2503%)	—	—
EPS Growth YoY (%)	-59.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	16.1% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-21.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-46.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	18.8% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-63.9% Weak ↓ Weak Declining Year-over-year change in net income	-11.6% Weak ↑ Weak Improving Year-over-year change in net income	-25.9% Weak ↑ Weak Improving Year-over-year change in net income	-59.3% Weak ↓ Weak Declining Year-over-year change in net income	-18.0% Weak ↓ Weak Declining Year-over-year change in net income	-17.5% Weak ↓ Weak Declining Year-over-year change in net income	66.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-62.5% Weak ↓ Weak Declining Year-over-year change in net income	27.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-1.0% Weak ↑ Weak Improving Year-over-year change in net income	-7.7% Weak ↑ Weak Improving Year-over-year change in net income	-44.8% Weak ↑ Weak Improving Year-over-year change in net income	-37.9% Weak ↑ Weak Improving Year-over-year change in net income	-32.0% Weak ↑ Weak Improving Year-over-year change in net income	-1668.6% Weak Weak Year-over-year change in net income	93.1% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	-29.7% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-13.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	14.7% Good ↑ Good Improving Compound annual revenue growth over 3 years	-2.5% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-12.9% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-21.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-16.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-19.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	20.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	52.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	18.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-21.2% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-27.1% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-55.5% Weak Weak Compound annual revenue growth over 3 years	-9.6% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	-26.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	14.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-6.3% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-28.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-7.3% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	6.2% Fair ↓ Fair Declining Compound annual revenue growth over 5 years	-0.1% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	18.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	2.6% Caution ↑ Caution Improving Compound annual revenue growth over 5 years	-6.0% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-34.9% Weak Weak Compound annual revenue growth over 5 years	-25.1% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-468.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3223%)	-13.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-192%)	-242.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1718%)	—
Effective Tax Rate (%) (%)	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	20.7% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	1.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-483.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4129%)	-5.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-145%)	-240.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2105%)	—
FCF / Net Income (x)	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	-54.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-46.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-125.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-40.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-39.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-45.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-47.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-49.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-49.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-49.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-44.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-100.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-34.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-49.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-46.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-44.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-5.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-49.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-427%)	-21.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-241%)	-33.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-320%)	-34.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-330%)	-16.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-212%)	-28.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-290%)	-54.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-461%)	-121.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-912%)	-39.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-362%)	-48.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-423%)	-43.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-392%)	-55.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-472%)	-25.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-270%)	-61.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-512%)	-65.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-535%)	-3.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-122%)	-49.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-430%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	-87.86x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-36.85x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-24.16x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.83x Weak Weak Operating income divided by interest expense Optimal: > 5x	-81.53x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-28.87M	$-28.36M	$-34.81M	$-29.43M	$-39.14M	$-43.84M	$-11.23M	$-24.31M	$-40.29M	$-42.46M	$-72.11M	$-28.02M	$-169.40M	$-24.90M	$-11.90M	$-21.29M	$-57.00M	$-44.26M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$0.02	$0.11	—	—	—	—	—	—	—	—	—	—	—	—	$3.50	$21.92	$11.43	—
Basic EPS, GAAP (USD)	$-3.90	$-2.45	$-2.92	$-2.40	$-1.64	$-2.02	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-3.22	$-2.48	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$7.92	$11.25	$7.68	$6.91	$8.98	$5.29	$5.54	$10.37	$25.60	$32.87	$43.88	$35.26	$53.48	$22.21	$23.20	$35.04	$55.54	—
Tangible Book Value per Share (USD)	$7.51	$10.84	$7.19	$6.33	$8.39	$4.51	$2.67	$6.30	$8.42	$11.51	$39.38	$30.13	$48.17	$14.60	$11.76	$18.37	$55.54	—
Basic Weighted Avg Shares (shares)	66.42M	64.39M	48,449	46,888	42,870	29,640	—	—	—	—	—	—	—	—	2.65M	2.14M	1.33M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$483.67M	$707.66M	$400.57M	$299.08M	$394.31M	$183.64M	$55.05M	$86.48M	$117.02M	$160.35M	$264.70M	$180.49M	$284.84M	$67.43M	$40.39M	$42.74M	—	—
Total Equity (USD)	$527.16M	$747.00M	$429.17M	$326.20M	$419.48M	$209.36M	$94.03M	$124.06M	$236.37M	$265.43M	$290.11M	$211.66M	$319.80M	$95.77M	$68.72M	$75.25M	$73.77M	$18.13M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$1.54M	$7.02M	$6.88M	$2.36M	$4.65M	$7.42M	$3.57M	$9.54M	$12.74M	$6.79M	$5.48M	$3.59M	$4.11M	$11.20M	$9.27M	$46.79M	$15.18M	—
Depreciation Expense (USD)	$3.38M	$3.18M	$3.01M	$2.90M	$3.07M	$3.93M	$4.86M	$3.58M	$4.41M	$3.10M	$3.00M	$2.39M	$1.93M	$2.05M	$2.25M	$2.72M	$2.58M	—
Net Income, GAAP (USD)	$-258.76M	$-157.86M	$-141.43M	$-112.33M	$-70.51M	$-59.78M	$-50.88M	$-151.18M	$-93.03M	$-128.53M	$-127.20M	$-118.08M	$-81.55M	$-59.12M	$-44.80M	$-2.53M	$-36.52M	—
Operating Cash Flow (USD)	$-210.94M	$-157.78M	$-107.29M	$-103.73M	$-60.91M	$-40.40M	$-46.41M	$-75.23M	$-99.93M	$-113.04M	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters

Celldex Therapeutics, Inc.

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CLDX with peers